Journal Mobile Options
Table of Contents
Vol. 25, No. 4, 2005
Issue release date: October 2005
Neuroepidemiology 2005;25:181–191

The Aging, Demographics, and Memory Study: Study Design and Methods

Langa K.M. · Plassman B.L. · Wallace R.B. · Herzog A.R. · Heeringa S.G. · Ofstedal M.B. · Burke J.R. · Fisher G.G. · Fultz N.H. · Hurd M.D. · Potter G.G. · Rodgers W.L. · Steffens D.C. · Weir D.R. · Willis R.J.
aDivision of General Medicine, Department of Medicine, bVeterans Affairs Center for Practice Management and Outcomes Research, cInstitute for Social Research, dInstitute for Research on Women and Gender, University of Michigan, Ann Arbor, Mich., eDepartment of Psychiatry and Behavioral Sciences, fDepartment of Medicine (Neurology), Duke University Medical Center, Durham, N.C., gColleges of Public Health and Medicine, University of Iowa, Iowa City, Iowa, and hRAND, Santa Monica, Calif., USA

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Objective: We describe the design and methods of the Aging, Demographics, and Memory Study (ADAMS), a new national study that will provide data on the antecedents, prevalence, outcomes, and costs of dementia and ‘cognitive impairment, not demented’ (CIND) using a unique study design based on the nationally representative Health and Retirement Study (HRS). We also illustrate potential uses of the ADAMS data and provide information to interested researchers on obtaining ADAMS and HRS data. Methods: The ADAMS is the first population-based study of dementia in the United States to include subjects from all regions of the country, while at the same time using a single standardized diagnostic protocol in a community-based sample. A sample of 856 individuals age 70 or older who were participants in the ongoing HRS received an extensive in-home clinical and neuropsychological assessment to determine a diagnosis of normal, CIND, or dementia. Within the CIND and dementia categories, subcategories (e.g. Alzheimer’s disease, vascular dementia) were assigned to denote the etiology of cognitive impairment. Conclusion: Linking the ADAMS dementia clinical assessment data to the wealth of available longitudinal HRS data on health, health care utilization, informal care, and economic resources and behavior, will provide a unique opportunity to study the onset of CIND and dementia in a nationally representative population-based sample, as well as the risk factors, prevalence, outcomes, and costs of CIND and dementia.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Brookmeyer R, Gray S, Kawas C: Projections of Alzheimer’s disease in the United States and the public health impact of delaying disease onset. Am J Public Health 1998;88:1337–1342.
  2. Langa K, Chernew M, Kabeto M, et al: National estimates of the quantity and cost of informal caregiving for the elderly with dementia. J Gen Intern Med 2001;16:770–778.
  3. Ernst RL, Hay JW: Economic research on Alzheimer disease: a review of the literature. Alzheimer Dis Assoc Disord 1997;11(suppl 6):135–145.

    External Resources

  4. Juster FT, Suzman R: An overview of the Health and Retirement Study. J Hum Resour 1995;30(suppl):S7–S56.

    External Resources

  5. Brandt J, Spencer M, Folstein M: The telephone interview for cognitive status. Neuropsychiatry Neuropsychol Behav Neurol 1988;1:111–117.
  6. Herzog A, Wallace R: Measures of cognitive functioning in the AHEAD study. J Gerontol B 1997;52B:37–48.

    External Resources

  7. Folstein MF, Folstein SE, McHugh PR: ‘Mini-mental state’. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–198.
  8. Plassman BL, Newman T, Welsh K, Breitner J: Properties of the telephone interview for cognitive status. Application in epidemiological and longitudinal studies. Neuropsychiatry Neuropsychol Behav Neurol 1994;7:235–241.

    External Resources

  9. Welsh K, Breitner J, Magruder-Habib K: Detection of dementia in the elderly using telephone screening of cognitive status. Neuropsychiatry Neuropsychol Behav Neurol 1993;6:103–110.

    External Resources

  10. Jorm A: A short form of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): development and cross-validation. Psychol Med 1994;24:145–153.
  11. Jorm A, Jacomb P: The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms. Psychol Med 1989;19:1015–1022.
  12. Ofstedal MB, Fisher G, Herzog AR: Documentation of Cognitive Functioning Measures in the Health and Retirement Study. Ann Arbor, University of Michigan, 2005.
  13. Breitner J, Welsh K, Gaur B, et al: Alzheimer’s disease in the National Academy of Sciences-National Research Council registry of aging twin veterans. III. Detection of cases, longitudinal results, and observations on twin concordance. Arch Neurol 1995;52:763–771.
  14. Tschanz JT, Welsh-Bohmer KA, Skoog I, et al: Dementia diagnoses from clinical and neuropsychological data compared. The Cache County study. Neurology 2000;54:1290–1296.
  15. Plassman B, Havlik R, Steffens D, et al: Documented head injury in early adulthood and risk of Alzheimer’s disease and other dementias. Neurology 2000;55:1158–1166.
  16. Breitner JC, Welsh KA, Robinette CD, Gau BA, Folstein MF, Brandt J: Alzheimer’s disease in the NAS-NRC registry of aging twin veterans. II. Longitudinal findings in a pilot series. National Academy of Sciences. National Research Council Registry. Dementia 1994;5:99–105.
  17. Welsh K, Butters N, Hughes J, Mohs R, Heyman A: Detection of abnormal memory decline in mild cases of Alzheimer’s disease using CERAD neuropsychological measures. Arch Neurol 1991;48:278–281.
  18. Welsh K, Fillenbaum G, Wilkinson W, et al: Neuropsychological test performance in African-American and white patients with Alzheimer’s disease. Neurology 1995;45:2207–2211.
  19. Fillenbaum G, Heyman A, Huber M, Ganguli M, Unverzagt F: Performance of elderly African American and White community residents on the CERAD Neuropsychological Battery. J Int Neuropsychol Soc 2001;7:502–509.
  20. Ganguli M, Chandra V, Gilby JE, et al: Cognitive test performance in a community-based nondemented elderly sample in rural India: the Indo-U.S. Cross-National Dementia Epidemiology Study. Int Psychogeriatr 1996;8:507–524.
  21. Prince M, Acosta D, Chiu H, Scazufca M, Varghese M: Dementia diagnosis in developing countries: a cross-cultural validation study. Lancet 2003;361:909–917.
  22. Clark CM, Ewbank DC: Performance of the dementia severity rating scale: a caregiver questionnaire for rating severity in Alzheimer disease. Alzheimer Dis Assoc Dis 1996;10:31–39.
  23. Morris JC: The clinical dementia rating (CDR): current version and scoring rules. Neurology 1993;43:2412–2414.
  24. Rosen W, Terry R, Fuld P, Katzman R, Peck A: Pathological verification of ischemic score in differentiation of dementias. Ann Neurol 1980;7:486–488.
  25. Oldfield R: The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 1971;9:97–113.
  26. Schulz R, Beach S, Lind B, et al: Involvement in caregiving and adjustment to death of a spouse. Findings from the caregiver health effects study. JAMA 2001;285:3123–3129.
  27. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 3, revised. Washington, American Psychiatric Association, 1987.
  28. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, American Psychiatric Association, 1994.
  29. Wainwright NW, Surtees PG, Gilks WR: Diagnostic boundaries, reasoning and depressive disorder. I. Development of a probabilistic morbidity model for public health psychiatry. Psychol Med 1997;27:835–845.
  30. Canadian Study of Health and Aging Working Group: Canadian Study of Health and Aging: study methods and prevalence of dementia. Can Med Assoc J 1994;150:899–913.
  31. Mexican Health and Aging Study. 2004. Accessed May 3, 2004.
  32. English Longitudinal Study of Ageing. 2004. Accessed May 3, 2004.
  33. Survey of Health and Aging in Europe. 2004. Accessed May 3, 2004.
  34. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 1984;34:939–944.
  35. Roman GC, Tatemichi TK, Erkinjuntti T, et al: Vascular dementia: diagnostic criteria for research studies. Report of the NINDS- AIREN International Workshop. Neurology 1993;43:250–260.
  36. The Lund and Manchester Groups: Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry 1994;57:416–418.
  37. McKeith IG, Galasko D, Kosaka K, et al: Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47:1113–1124.
  38. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E: Mild cognitive impairment. Arch Neurol 1999;56:303–308.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50